1-7 of 7
Ruby M. Wong
Close
Sort by
Journal Articles

Long-Term Outcomes of Myeloablative Conditioning and Matched-Related Donor Hematopoietic Cell Transplantation for Patients with High-Risk and Advanced-Stage Hematolymphoid Malignancies

Jonathan E. Benjamin, MD, PhD, Ginna G. Laport, MD, Laura J. Johnston, MD, Sally Arai, MD, Wen-Kai Weng, MD, PhD, Judith A. Shizuru, MD, PhD, David B. Miklos, MD, PhD, Ruby M. Wong, PhD, Linda V. Elder, Karl G. Blume, MD, Robert S. Negrin, MD, Robert Lowsky, MD
Journal: Blood
Blood (2008) 112 (11): 4383.
https://doi.org/10.1182/blood.V112.11.4383.4383
Published: 2008
Journal Articles

Functional Control of CMV Reactivation Is Profoundly Influenced by CMV Serostatus after Nonmyeloablative Hematopoietic Cell Transplantation Following a TLI-ATG Preparative Regimen.

Joanna Schaenman, M.D., Ph.D., Marcy L. Vana, Ph.D., Chanu Rhee, M.D., Jonathan Wong, Shelly Navato, Laura J. Johnston, M.D., Ruby M. Wong, Dora Y. Ho, M.D., Ph.D., Janice (Wes) Brown, M.D.
Journal: Blood
Blood (2008) 112 (11): 2238.
https://doi.org/10.1182/blood.V112.11.2238.2238
Published: 2008
Journal Articles

Long-term remission of Philadelphia chromosome–positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation from matched sibling donors: a 20-year experience with the fractionated total body irradiation–etoposide regimen

Ginna G. Laport, Joseph C. Alvarnas, Joycelynne M. Palmer, David S. Snyder, Marilyn L. Slovak, Athena M. Cherry, Ruby M. Wong, Robert S. Negrin, Karl G. Blume, Stephen J. Forman
Journal: Blood
Blood (2008) 112 (3): 903–909.
https://doi.org/10.1182/blood-2008-03-143115
Published: 2008
Journal Articles

Engraftment and survival following reduced-intensity allogeneic peripheral blood hematopoietic cell transplantation is affected by CD8 + T-cell dose

Clinical Trials & Observations
Thai M. Cao, Judith A. Shizuru, Ruby M. Wong, Kevin Sheehan, Ginna G. Laport, Keith E. Stockerl-Goldstein, Laura J. Johnston, Monic J. Stuart, F. Carl Grumet, Robert S. Negrin, Robert Lowsky
Journal: Blood
Blood (2005) 105 (6): 2300–2306.
https://doi.org/10.1182/blood-2004-04-1473
Published: 2005
Includes: Supplemental data
Journal Articles

Engraftment and Survival Following Non-Myeloablative Allogeneic Peripheral Blood Hematopoietic Cell Transplantation for Malignant Diseases Is Affected by CD8 + T-Cell Dose.

Thai M. Cao, MD, Judith A. Shizuru, PhD, MD, Ruby M. Wong, PhD, Kevin Sheehan, PhD, Ginna G. Laport, MD, Keith E. Stockerl-Goldstein, MD, Laura J. Johnston, MD, Monic J. Stuart, MD, Janic M.Y. Brown, MD, F. C. Grumet, MD, Robert S. Negrin, MD, Robert Lowsky, MD
Journal: Blood
Blood (2004) 104 (11): 183.
https://doi.org/10.1182/blood.V104.11.183.183
Published: 2004
Journal Articles

Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma

Clinical Trials & Observations
Steven M. Horwitz, Robert S. Negrin, Karl G. Blume, Sheila Breslin, Monic J. Stuart, Keith E. Stockerl-Goldstein, Laura J. Johnston, Ruby M. Wong, Judith A. Shizuru, Sandra J. Horning
Journal: Blood
Blood (2004) 103 (3): 777–783.
https://doi.org/10.1182/blood-2003-04-1257
Published: 2004
Journal Articles

High-Dose Therapy and Autologous Hematopoietic Progenitor Cell Transplantation for Recurrent or Refractory Hodgkin's Disease: Analysis of the Stanford University Results and Prognostic Indices

Sandra J. Horning, Nelson J. Chao, Robert S. Negrin, Richard T. Hoppe, Gwynn D. Long, Wendy W. Hu, Ruby M. Wong, Byron W. Brown, Karl G. Blume
Journal: Blood
Blood (1997) 89 (3): 801–813.
https://doi.org/10.1182/blood.V89.3.801
Published: 1997